JP5154835B2 - Whitening cosmetics - Google Patents
Whitening cosmetics Download PDFInfo
- Publication number
- JP5154835B2 JP5154835B2 JP2007123017A JP2007123017A JP5154835B2 JP 5154835 B2 JP5154835 B2 JP 5154835B2 JP 2007123017 A JP2007123017 A JP 2007123017A JP 2007123017 A JP2007123017 A JP 2007123017A JP 5154835 B2 JP5154835 B2 JP 5154835B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- snow
- formulation
- whitening
- melanin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002087 whitening effect Effects 0.000 title claims description 20
- 239000002537 cosmetic Substances 0.000 title claims description 12
- 239000000284 extract Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 241000534456 Arenaria <Aves> Species 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 description 27
- 241000222336 Ganoderma Species 0.000 description 20
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 20
- 238000009472 formulation Methods 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- 239000000469 ethanolic extract Substances 0.000 description 8
- 239000006210 lotion Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- -1 pH adjusters Substances 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000219051 Fagopyrum Species 0.000 description 4
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 210000004694 pigment cell Anatomy 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 125000000687 hydroquinonyl group Chemical class C1(O)=C(C=C(O)C=C1)* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、シミ、ソバカスや皮膚色素沈着等の原因となるメラニンの生成を抑制することによって、美白作用を発揮できる美白剤及び美白化粧料に関するものである。 The present invention relates to a whitening agent and a whitening cosmetic that can exhibit a whitening effect by suppressing the production of melanin that causes spots, buckwheat, skin pigmentation, and the like.
一般にメラニンは、色素細胞の中で生合成されるチロシナーゼの働きによって、チロシンからドーパ、ドーパからドーパキノンに変化し、5,6−ジヒドロキシインドフェノール等の中間体を経由して形成されるものとされている。シミ、ソバカスや皮膚色素沈着は、ホルモンの異常や紫外線の刺激により、皮膚内に存在するメラニン色素細胞がメラニン色素を過剰に生成し、これが皮膚内に沈着することが原因と考えられている。 In general, melanin changes from tyrosine to dopa and from dopa to dopaquinone by the action of tyrosinase biosynthesized in pigment cells, and is formed through intermediates such as 5,6-dihydroxyindophenol. ing. Spots, buckwheat, and skin pigmentation are thought to be caused by melanin pigment cells that are excessively produced in the skin due to hormonal abnormalities and stimulation of ultraviolet rays, which are deposited in the skin.
雪霊芝(Arenaria kansuensis Maxim.)は、チベット、甘粛、青海、四川西部など中国で多く分布する多年生の矮小草本で、石灰岩の高山の石の割れ目か、草原に生える。インフルエンザ、肺炎、黄疸、肋骨疼痛、淋痛を治すとして知られている。 Yen Ganoderma (Arenaria kansuensis Maxim.) Is a perennial dwarf herb that is widely distributed in China such as Tibet, Gansu, Qinghai, and Western Sichuan. Known to cure influenza, pneumonia, jaundice, rib pain, colic.
雪霊芝抽出物は、保湿剤として皮膚外用剤に配合されている例があるものの,雪霊芝抽出物にメラニン生成抑制効果があることや、雪霊芝抽出物を配合した化粧料に極めて優れた美白効果があることは全く知られていない。 Although there are cases where Yukigakushi extract is blended in topical skin preparations as a moisturizer, it is extremely effective for cosmetics containing Yukigakushiki extract that have the effect of inhibiting melanin production. It is not known at all that it has an excellent whitening effect.
従来、シミ、ソバカス等の予防や治療を目的とする美白化粧料には、L−アスコルビン酸及びその誘導体、ハイドロキノン誘導体、コウジ酸のピロン類、プラセンタエキス等の胎盤抽出物が配合されている。 Conventionally, whitening cosmetics for the purpose of prevention and treatment of stains, buckwheat and the like have been mixed with placenta extracts such as L-ascorbic acid and its derivatives, hydroquinone derivatives, kojic acid pyrones, and placenta extract.
これらの物質は、メラニン生成の抑制、生成したメラニンの淡色漂白作用等の効果を持ち、美白効果を発揮する物質として広く知られている。しかしながら、これらの物質を単独で使用した場合、保存安定性が十分でなく、その効果が発揮されなかったり、安全性に問題がある等の理由で十分なものではなかった。
上記の欠点を解消できる、優れた効果を持つ、天然物由来の美白化粧料の開発が望まれていた。 There has been a demand for the development of a whitening cosmetic composition derived from a natural product having an excellent effect capable of eliminating the above disadvantages.
本発明は、雪霊芝(Arenaria kansuensis Maxim.)抽出物に美白効果があることを見出し、さらに雪霊芝抽出物を含有する化粧料に優れた美白効果があることを見出し、本発明を完成するに至った。 The present invention has found that an extract of snow ganoderma (Arenaria kansuensis Maxim.) Has a whitening effect, and further found that a cosmetic containing a snow ganoderma extract has an excellent whitening effect, thereby completing the present invention. It came to do.
本発明に用いる雪霊芝の抽出物とは、植物体の葉、茎、花、根等の植物体の一部又は全草から抽出したものである。好ましくは、植物体の全草から抽出して得られるものが良い。その抽出方法は特に限定されず、例えば、加熱抽出したものであっても良いし、常温抽出したものであっても良い。 The extract of snow ganoderma used in the present invention is extracted from a part of the plant body such as leaves, stems, flowers, roots or the whole plant. Preferably, the one obtained by extracting from the whole plant plant is good. The extraction method is not particularly limited, and for example, it may be a heat extraction or a room temperature extraction.
抽出する溶媒としては、例えば、水、低級アルコール類(メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール等)、液状多価アルコール(1,3−ブチレングリコール、プロピレングリコール、グリセリン等)、ケトン類(アセトン、メチルエチルケトン等)、アセトニトリル、エステル類(酢酸エチル、酢酸ブチル等)、炭化水素類(ヘキサン、ヘプタン、流動パラフィン等)、エーテル類(エチルエーテル、テトラヒドロフラン、プロピルエーテル等)が挙げられる。好ましくは、水、低級アルコール及び液状多価アルコール等の極性溶媒が良く、特に好ましくは、水、エタノール、1,3−ブチレングリコール及びプロピレングリコールが良い。これらの溶媒は一種でも二種以上を混合して用いても良い。 Examples of the solvent to be extracted include water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1,3-butylene glycol, propylene glycol). , Glycerin, etc.), ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, liquid paraffin, etc.), ethers (ethyl ether, tetrahydrofuran, propyl ether) Etc.). Preferred are polar solvents such as water, lower alcohols and liquid polyhydric alcohols, and particularly preferred are water, ethanol, 1,3-butylene glycol and propylene glycol. These solvents may be used alone or in combination of two or more.
雪霊芝抽出物は、抽出した溶液のまま用いても良く、必要に応じて、濃縮、希釈及び濾過処理、活性炭等による脱色、脱臭処理等をして用いても良い。更には、抽出した溶液を濃縮乾固、噴霧乾燥、凍結乾燥等の処理を行い、乾燥物として用いても良い。 The snow ganoderma extract may be used as it is, and may be used after concentration, dilution and filtration treatment, decolorization with activated carbon, deodorization treatment, or the like, if necessary. Further, the extracted solution may be subjected to a treatment such as concentration to dryness, spray drying, freeze drying, etc., and used as a dried product.
雪霊芝抽出物の配合量は、特に限定されないが、本発明の美白化粧料全量に対し、固形物に換算して0.0001重量%(以下、単に「%」で示す)〜5%、好ましくは0.001%〜1%の配合が良い。0.0001%未満では十分な効果が得られない場合があり、5%以上の配合では、美白化粧料の外観に影響を与えることがあるため、好ましくない。また、添加の方法については、予め加えておいても、製造途中で添加しても良く、作業性を考えて適宜選択すれば良い。 The blending amount of the snow ganoderma extract is not particularly limited, but is 0.0001% by weight (hereinafter simply referred to as “%”) to 5% in terms of solids based on the total amount of the whitening cosmetic of the present invention, Preferably, 0.001% to 1% is blended. If it is less than 0.0001%, a sufficient effect may not be obtained, and if it is 5% or more, the appearance of the whitening cosmetic composition may be affected. In addition, the addition method may be added in advance or during the production, and may be appropriately selected in consideration of workability.
本発明の美白化粧料には、必要に応じ、本発明の効果を損なわない範囲において、雪霊芝抽出物の他に、生理活性物質や基材、安定化成分等の任意成分を適宜配合することができる。このような任意成分としては、例えば精製水、油脂類、ロウ類、炭化水素類、脂肪酸類、アルコール類、エステル類、界面活性剤、金属石鹸、pH調整剤、防腐剤、香料、保湿剤、粉体、紫外線吸収剤、増粘剤、色素、酸化防止剤、美白剤、キレート剤等が挙げられる。 In the whitening cosmetics of the present invention, optional components such as a physiologically active substance, a base material, and a stabilizing component are appropriately blended in addition to the snow ganoderma extract as long as the effects of the present invention are not impaired. be able to. Examples of such optional components include purified water, fats and oils, waxes, hydrocarbons, fatty acids, alcohols, esters, surfactants, metal soaps, pH adjusters, preservatives, perfumes, moisturizers, Examples thereof include powders, ultraviolet absorbers, thickeners, dyes, antioxidants, whitening agents, chelating agents and the like.
本発明の美白化粧料の剤型としては、例えば、化粧水、クリ−ム、乳液、ゲル剤、エアゾール剤、エッセンス、パック、洗浄剤、浴用剤、ファンデ−ション、打粉、口紅等が挙げられる。 Examples of the dosage form of the whitening cosmetic of the present invention include skin lotion, cream, emulsion, gel, aerosol, essence, pack, cleaning agent, bath preparation, foundation, dusting, lipstick and the like. .
本発明の美白化粧料は、雪霊芝(Arenaria kansuensis Maxim.)抽出物を配合することを特徴とし、優れた美白効果を発揮する。 The whitening cosmetic composition of the present invention is characterized by blending an extract of Arenaria kansuensis maxim. And exhibits an excellent whitening effect.
次に本発明を詳細に説明するため、実施例として本発明に用いる抽出物の製造例、本発明の処方例及び実験例を挙げるが、本発明はこれに限定されるものではない。実施例に示す配合量の部とは重量部を、%とは重量%を示す。 Next, in order to describe the present invention in detail, examples of producing the extract used in the present invention, formulation examples and experimental examples of the present invention will be given as examples, but the present invention is not limited thereto. In the examples, the part of the amount is part by weight, and% is% by weight.
製造例1 雪霊芝の熱水抽出物
雪霊芝の全草75gに精製水1500mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥して雪霊芝の熱水抽出物を0.8g得た。
Production Example 1 Hot Water Extract of Snow Reishi Mushrooms Add 1500 ml of purified water to 75 g of Snow Reishi grass, extract at 95-100 ° C for 2 hours, filter, concentrate the filtrate, freeze-dry and snow 0.8 g of hot water extract of Ganoderma was obtained.
製造例2 雪霊芝の30%エタノール抽出物
雪霊芝の地上部75gに30%エタノール1500mLを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、雪霊芝の30%エタノール抽出物を2.4g得た。
Production Example 2 Snow Ganoderma 30% Ethanol Extract To 75 g of snow ganoderma on the ground, 1500 mL of 30% ethanol is added, extracted at room temperature for 7 days, filtered, and the filtrate is concentrated to dryness. 2.4 g of 30% ethanol extract was obtained.
製造例3 雪霊芝のエタノール抽出物
雪霊芝の全草75gにエタノール1500mLを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、雪霊芝のエタノール抽出物を3.1g得た。
Production Example 3 Snow Ganoderma Ethanol Extract Add 1500 mL of ethanol to 75 g of snow ganoderma grass, extract for 7 days at room temperature, filter, concentrate the filtrate to dryness, and extract the ethanol extract of snow ganoderma. 3.1g was obtained.
処方例1 化粧水A
処方 配合量
1.雪霊芝の熱水抽出物(製造例1) 0.1部
2.1,3−ブチレングリコール 3.0
3.グリセリン 1.0
4.キサンタンガム 0.02
5.クエン酸 0.01
6.クエン酸ナトリウム 0.1
7.エタノール 1.0
8.パラオキシ安息香酸メチル 0.1
9.ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.1
10.香料 適量
11.精製水にて全量を100とする
[製造方法]成分1〜6及び11と、成分7〜10をそれぞれ均一に溶解し、両者を混合し濾過して製品とする。
Formulation Example 1 Lotion A
Formulation Formulation 1. Snow Ganoderma Hot Water Extract (Production Example 1) 0.1 part 2.1,3-butylene glycol 3.0
3. Glycerin 1.0
4). Xanthan gum 0.02
5. Citric acid 0.01
6). Sodium citrate 0.1
7). Ethanol 1.0
8). Methyl paraoxybenzoate 0.1
9. Polyoxyethylene hydrogenated castor oil (40E.O.) 0.1
10. Perfume proper amount11. [Manufacturing method] Components 1 to 6 and 11 and components 7 to 10 are uniformly dissolved in purified water, and both are mixed and filtered to obtain a product.
比較例1 従来の化粧水
処方例1において、雪霊芝の熱水抽出物のみを精製水に置き換えたものを化粧水Bとした。
Comparative Example 1 Conventional lotion In Formulation 1, lotion B was obtained by replacing only the hot water extract of snow ganoderma with purified water.
処方例2 クリームA
処方 配合量
1.雪霊芝の30%エタノール抽出物(製造例2) 0.1部
2.スクワラン 5.5
3.オリーブ油 3.0
4.ステアリン酸 2.0
5.ミツロウ 2.0
6.ミリスチン酸オクチルドデシル 3.5
7.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
8.ベヘニルアルコール 1.5
9.モノステアリン酸グリセリン 2.5
10.香料 0.1
11.パラオキシ安息香酸メチル 0.2
12.パラオキシ安息香酸エチル 0.05
13.1,3−ブチレングリコール 8.5
14.精製水にて全量を100とする
[製造方法]成分2〜9を加熱溶解して混合し、70℃に保ち油相とする。成分1及び11〜14を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分10を加え、更に30℃まで冷却して製品とする。
Formulation Example 2 Cream A
Formulation Formulation 1. Snow Ganoderma 30% ethanol extract (Production Example 2) 0.1 part Squalane 5.5
3. Olive oil 3.0
4). Stearic acid 2.0
5. Beeswax 2.0
6). Octyldodecyl myristate 3.5
7). Polyoxyethylene cetyl ether (20E.O.) 3.0
8). Behenyl alcohol 1.5
9. Glycerol monostearate2.5
10. Fragrance 0.1
11. Methyl paraoxybenzoate 0.2
12 Ethyl paraoxybenzoate 0.05
13.1,3-Butylene glycol 8.5
14 [Manufacturing method] Components 2 to 9 are heated and dissolved and mixed with purified water to a total amount of 100, and kept at 70 ° C to obtain an oil phase. Ingredients 1 and 11 to 14 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled while stirring. The component 10 is added at 45 ° C., and further cooled to 30 ° C. to obtain a product.
比較例2 従来のクリーム
処方例2において、雪霊芝の30%エタノール抽出物のみを精製水に置き換えたものをクリームBとした。
Comparative Example 2 Conventional Cream In Formulation Example 2, cream B was obtained by replacing only 30% ethanol extract of snow ganoderma with purified water.
処方例3 乳液
処方 配合量
1.雪霊芝の熱水抽出物(製造例1) 0.5部
2.スクワラン 5.0
3.オリーブ油 5.0
4.ホホバ油 5.0
5.セタノール 1.5
6.モノステアリン酸グリセリン 2.0
7.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
8.ポリオキシエチレンソルビタンモノオレエート
(20E.O.) 2.0
9.香料 適量
10.プロピレングリコール 1.0
11.グリセリン 2.0
12.パラオキシ安息香酸メチル 0.2
13.精製水にて全量を100とする
[製造方法]成分2〜8を加熱溶解して混合し、70℃に保ち油相とする。成分1及び10〜13を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分9を加え、更に30℃まで冷却して製品とする。
Formulation Example 3 Emulsion Formulation Formulation 1. Snow Reishi Hot Water Extract (Production Example 1) 0.5 part Squalane 5.0
3. Olive oil 5.0
4). Jojoba oil 5.0
5. Cetanol 1.5
6). Glycerol monostearate 2.0
7). Polyoxyethylene cetyl ether (20E.O.) 3.0
8). Polyoxyethylene sorbitan monooleate (20E.O.) 2.0
9. Perfume appropriate amount10. Propylene glycol 1.0
11. Glycerin 2.0
12 Methyl paraoxybenzoate 0.2
13. [Manufacturing method] Components 2 to 8 are heated and dissolved and mixed with purified water to a total amount of 100, and kept at 70 ° C to obtain an oil phase. Ingredients 1 and 10-13 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled while stirring. The component 9 is added at 45 ° C., and further cooled to 30 ° C. to obtain a product.
処方例4 ゲル剤
処方 配合量
1.雪霊芝のエタノール抽出物(製造例3) 0.001部
2.エタノール 5.0
3.パラオキシ安息香酸メチル 0.1
4.ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.1
5.香料 適量
6.1,3−ブチレングリコール 5.0
7.グリセリン 5.0
8.キサンタンガム 0.1
9.カルボキシビニルポリマー 0.2
10.水酸化カリウム 0.2
11.精製水にて全量を100とする
[製造方法]成分1〜5と、成分6〜11をそれぞれ均一に溶解し、両者を混合して製品とする。
Formulation Example 4 Gel formulation Formulation amount 1. Snow Ganoderma Ethanol Extract (Production Example 3) 0.001 part Ethanol 5.0
3. Methyl paraoxybenzoate 0.1
4). Polyoxyethylene hydrogenated castor oil (60 EO) 0.1
5. Perfume appropriate amount 6.1,3-butylene glycol 5.0
7). Glycerin 5.0
8). Xanthan gum 0.1
9. Carboxyvinyl polymer 0.2
10. Potassium hydroxide 0.2
11. [Production method] Ingredients 1 to 5 and 6 to 11 are uniformly dissolved in purified water to 100, and both are mixed to obtain a product.
処方例5 ファンデーション
処方 配合量
1.雪霊芝の熱水抽出物(製造例1) 0.05部
2.ステアリン酸 2.4
3.ポリオキシエチレンソルビタンモノステアレート
(20E.O.) 1.0
4.ポリオキシエチレンセチルエーテル(20E.O.) 2.0
5.セタノール 1.0
6.液状ラノリン 2.0
7.流動パラフィン 3.0
8.ミリスチン酸イソプロピル 6.5
9.カルボキシメチルセルロースナトリウム 0.1
10.ベントナイト 0.5
11.プロピレングリコール 4.0
12.トリエタノールアミン 1.1
13.パラオキシ安息香酸メチル 0.2
14.二酸化チタン 8.0
15.タルク 4.0
16.ベンガラ 1.0
17.黄酸化鉄 2.0
18.香料 適量
19.精製水にて全量を100とする
[製造方法]成分2〜8を加熱溶解し、80℃に保ち油相とする。成分19に成分9をよく膨潤させ、続いて、成分1及び10〜13を加えて均一に混合する。これに粉砕機で粉砕混合した成分14〜17を加え、ホモミキサーで撹拌し75℃に保ち水相とする。この水相に油相をかき混ぜながら加え、冷却し、45℃で成分18を加え、かき混ぜながら30℃まで冷却して製品とする。
Formulation Example 5 Foundation Formulation Amount 0.05 parts of hot water extract of Snow Reishi (Production Example 1) Stearic acid 2.4
3. Polyoxyethylene sorbitan monostearate (20EO) 1.0
4). Polyoxyethylene cetyl ether (20E.O.) 2.0
5. Cetanol 1.0
6). Liquid lanolin 2.0
7). Liquid paraffin 3.0
8). Isopropyl myristate 6.5
9. Sodium carboxymethylcellulose 0.1
10. Bentonite 0.5
11. Propylene glycol 4.0
12 Triethanolamine 1.1
13. Methyl paraoxybenzoate 0.2
14 Titanium dioxide 8.0
15. Talc 4.0
16. Bengala 1.0
17. Yellow iron oxide 2.0
18. Perfume proper amount19. [Manufacturing method] Components 2 to 8 are heated and dissolved in purified water to a total amount of 100, and kept at 80 ° C to obtain an oil phase. Swell component 9 well in component 19, then add components 1 and 10-13 and mix uniformly. To this, components 14 to 17 pulverized and mixed with a pulverizer are added, and the mixture is stirred with a homomixer and kept at 75 ° C. to obtain an aqueous phase. The oil phase is added to this aqueous phase with stirring, cooled, component 18 is added at 45 ° C., and cooled to 30 ° C. with stirring to give a product.
次に、本発明の効果を詳細に説明するため、実験例を挙げる。 Next, experimental examples will be given to explain the effects of the present invention in detail.
実験例1 B16マウスメラノーマを用いたメラニン生成抑制試験
雪霊芝の熱水抽出物(製造例1)、30%エタノール抽出物(製造例2)を試料として用い、メラニン生成抑制作用を測定した。
Experimental Example 1 Melanin Production Inhibition Test Using B16 Mouse Melanoma A melanin production inhibitory effect was measured using a hot water extract of Snow Reishi (Production Example 1) and a 30% ethanol extract (Production Example 2) as samples.
マウスメラノーマ由来細胞株であるB16細胞を6cmディッシュに3×104個播種し、10%FBSを含むMEM with NEAAにて5%CO2、37℃条件下で5日間培養した。その時、それぞれの試料は、最終濃度を調整して添加した。次に、細胞をPBS(−)にて2回洗浄した後、PBS(−)1mLを加え、ラバーポリスマンにて集めた。遠心操作をして得られたペレットにPBS(−)0.5mLを加え、超音波破砕操作をしてペレットを溶解させた。タンパク定量はLowry法{Lowry,O.H.et al.,J.Biol.Chem.,193,265−275(1951)}により測定した。また、1mgタンパクあたりのメラニン量を測定する場合、タンパク定量用に取った残りの細胞破砕溶液に4N水酸化ナトリウム0.5mLを加え、60℃で2時間反応させた後O.D.475を測定し、検量線からメラニン定量を行った。データは1mgタンパクあたりのメラニン量を算出し、試料未添加のメラニン生成量をコントロールとし、コントロールに対する試料添加時のメラニン生成量の値からメラニン生成抑制率を算出した。 B16 cells, a mouse melanoma-derived cell line, were seeded at 3 × 10 4 cells in a 6 cm dish, and cultured for 5 days in MEM with NEAA containing 10% FBS under 5% CO 2 and 37 ° C. conditions. At that time, each sample was added after adjusting the final concentration. Next, after the cells were washed twice with PBS (−), 1 mL of PBS (−) was added and collected with a rubber policeman. PBS (-) 0.5mL was added to the pellet obtained by centrifugation, and the pellet was dissolved by ultrasonic crushing operation. Protein quantification was performed using the Lowry method {Lowry, O .; H. et al. , J .; Biol. Chem. , 193, 265-275 (1951)}. When measuring the amount of melanin per mg protein, 0.5 mL of 4N sodium hydroxide was added to the remaining cell disruption solution taken for protein quantification and reacted at 60 ° C. for 2 hours. D. 475 was measured, and melanin was determined from the calibration curve. The data calculated the amount of melanin per 1 mg protein, the amount of melanin not added to the sample was taken as a control, and the inhibition rate of melanin generation was calculated from the value of the amount of melanin generated when the sample was added to the control.
これらの実験結果を表1に示した。雪霊芝抽出物はメラニン生成抑制効果があり、さらに熱水抽出物の方が、優れたメラニン生成抑制効果を示した。 The results of these experiments are shown in Table 1. The snow ganoderma extract had a melanin production inhibitory effect, and the hot water extract showed a superior melanin production inhibitory effect.
実験例2 使用試験
処方例1の化粧水A、比較例1の従来の化粧水B、並びに処方例2のクリームA、比較例2の従来のクリームBを用いて、シミ、ソバカスに悩む女性、それぞれ20人(21〜46才)を対象に1ヶ月間の使用試験を行った。使用後、シミ、ソバカスの改善効果をアンケートにより判定した。
Experimental Example 2 Use Test A woman suffering from spots and freckles using the lotion A of Formulation Example 1, the conventional lotion B of Comparative Example 1 and the cream A of Formulation Example 2 and the conventional cream B of Comparative Example 2. A 20-month use test was conducted for 20 people (21 to 46 years old). After use, the effect of improving spots and freckles was judged by a questionnaire.
これらの試験結果を表2及び表3に示した。雪霊芝抽出物を配合した化粧水AとクリームAは優れたシミ、ソバカスの改善効果を示した。なお、試験期間中、皮膚トラブルは一人もなく、安全性においても問題なかった。また、処方成分の劣化についても問題なかった。 These test results are shown in Tables 2 and 3. Skin lotion A and cream A formulated with snow ganoderma extract showed excellent stain and buckwheat improvement effects. During the test period, there was no skin problem and there was no problem with safety. There was also no problem with the deterioration of the prescription ingredients.
処方例3〜5についても良好な美白効果があった。 Formulation Examples 3 to 5 also had a good whitening effect.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007123017A JP5154835B2 (en) | 2007-05-08 | 2007-05-08 | Whitening cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007123017A JP5154835B2 (en) | 2007-05-08 | 2007-05-08 | Whitening cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008280249A JP2008280249A (en) | 2008-11-20 |
JP5154835B2 true JP5154835B2 (en) | 2013-02-27 |
Family
ID=40141368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007123017A Active JP5154835B2 (en) | 2007-05-08 | 2007-05-08 | Whitening cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5154835B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012121828A (en) * | 2010-12-08 | 2012-06-28 | Nippon Menaade Keshohin Kk | Phototoxicity inhibitor |
JP5666344B2 (en) * | 2011-02-28 | 2015-02-12 | 日本メナード化粧品株式会社 | Hair restorer |
KR101297359B1 (en) * | 2011-03-10 | 2013-08-14 | 한불화장품주식회사 | Skin agent composition containing fermented Arenaria kansuensis Maxim. extract |
CN105708786A (en) * | 2014-12-03 | 2016-06-29 | 北京丽倍生科技有限责任公司 | Traditional Chinese medicine composition and preparation method thereof, and composition comprising traditional Chinese medicine composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003113030A (en) * | 2001-09-28 | 2003-04-18 | Ts Aasu:Kk | Skin care preparation |
JP4781062B2 (en) * | 2005-09-14 | 2011-09-28 | 株式会社ノエビア | Skin preparation for moisturizing or improving rough skin |
-
2007
- 2007-05-08 JP JP2007123017A patent/JP5154835B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008280249A (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009029734A (en) | External preparation for skin | |
JP5154835B2 (en) | Whitening cosmetics | |
JP5184840B2 (en) | Topical skin preparation | |
JP2003192566A (en) | Cosmetic | |
JP2002370922A (en) | Cosmetic containing japanese plum extract | |
JP2003095858A (en) | Skin care preparation | |
JP4824181B2 (en) | Topical skin preparation | |
JP5138262B2 (en) | Topical skin preparation | |
JP4628604B2 (en) | Skin preparation | |
JP5144362B2 (en) | Topical skin preparation | |
JP2005023021A (en) | Elastase inhibitor | |
JP6281761B2 (en) | External preparation or internal preparation containing Hidakami Sebaya extract | |
JP6468595B2 (en) | Topical skin preparation | |
JP5468866B2 (en) | Topical skin preparation | |
JP2015093848A (en) | Skin cosmetic and hair cosmetic | |
JP5690149B2 (en) | External preparation or internal preparation | |
JP5710193B2 (en) | Topical skin preparation | |
JP5415216B2 (en) | Topical skin preparation | |
JP2007191438A (en) | Desmosome degradation-promoting agent | |
JP6433678B2 (en) | External preparations and internal preparations containing the extract | |
JP2004203777A (en) | Ageing-preventing and improving cosmetic | |
JP3930179B2 (en) | Topical skin preparation | |
JP4473439B2 (en) | Whitening agent | |
JP2015205833A (en) | Whitening agent containing epiphyllum oxypetalum extract | |
JP2000319159A (en) | Skin preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100323 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111020 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120228 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120417 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120420 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120710 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121002 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20121010 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121204 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121206 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151214 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5154835 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |